develops therapeutic proteins based on its proprietary LEX System, an expression system that enables the production of hard-to-make proteins and the optimization of monoclonal antibodies.
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2024 All Rights Reserved
© 2022 All Rights Reserved